The role of the psychedelic experience in psilocybin treatment for treatment-resistant depression.
Goodwin GM. et al, (2025), J Affect Disord, 372, 523 - 532
Compass Psychological Support Model for COMP360 Psilocybin Treatment of Serious Mental Health Conditions.
Kirlić N. et al, (2025), Am J Psychiatry, 182, 126 - 132
The impact of antidepressant discontinuation prior to treatment with psilocybin for treatment-resistant depression.
Marwood L. et al, (2024), J Psychiatr Res, 180, 198 - 203
Exploring the incidence of inadequate response to antidepressants in the primary care of depression.
Abrahams AB. et al, (2024), Eur Neuropsychopharmacol, 83, 61 - 70
Hypersexuality in bipolar disorder: an overlooked symptom.
Dolman C. et al, (2024), Lancet Psychiatry, 11, 405 - 406
Comorbid physical health burden of serious mental health disorders in 32 European countries.
Wienand D. et al, (2024), BMJ Ment Health, 27
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects
E-Wen McCulloch D. et al, (2024), Neuroscience Applied, 3
Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective?
Pasculli G. et al, (2024), Front Hum Neurosci, 18
Psychological Support for Psilocybin Treatment: Reply to Letters on Our Commentary.
Goodwin GM. et al, (2024), Am J Psychiatry, 181, 79 - 81
A single dose of lamotrigine induces a positive memory bias in healthy volunteers
Zghoul T. et al, (2023)
Combining antidepressants and attention bias modification in primary health care (DEPTREAT): Protocol for a pragmatic randomized controlled trial.
Landrø NI. et al, (2023), Contemporary clinical trials, 133, 107326 - 107326
The psychedelic experience and treatment-resistant depression.
Goodwin GM., (2023), World Psychiatry, 22, 420 - 422
Psilocybin therapy for treatment resistant depression: prediction of clinical outcome by natural language processing.
Dougherty RF. et al, (2023), Psychopharmacology (Berl)
The IBER study: a feasibility randomised controlled trial of imagery based emotion regulation for the treatment of anxiety in bipolar disorder.
Steel C. et al, (2023), Int J Bipolar Disord, 11
Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication.
Goodwin GM. et al, (2023), Neuropsychopharmacology
A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression.
Jauhar S. et al, (2023), Mol Psychiatry
Unblinding and demand characteristics in the treatment of depression.
Goodwin GM. et al, (2023), J Affect Disord, 328, 1 - 5